Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 have?
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 has 22 citations in the OpenAlex counts ScholarIQ stores.
When was Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 published?
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 has 2021 year in the ScholarIQ index.
What is the open-access status of Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19?
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 has diamond oa status in the ScholarIQ index.
What is the DOI of Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19?
The DOI for Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 is on the source record.
What is the PMID of Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19?
The PMID for Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 is on the source record.
What is the OpenAlex record for Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19?
The OpenAlex for Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19 is on the source record.